What a prescribing limit actually does

The intuition behind a numeric prescribing limit is reasonable: too much of this drug is being prescribed, so cap it. The reason it does not work as intended is worth spelling out, because the same reasoning applies to most population-level instruments.

Why does an opioid prescribing limit treat every patient the same?

Clinical guidance says: reassess at this point, take extra precautions. A limit says: no. The first produces different actions for different patients. The second produces the same action for the patient whose metabolism makes a high number modest and the patient for whom a low number is already dangerous. Given roughly 13-fold variability in the dose people require, that is a lot of information being discarded.

Who makes the decision under a prescribing limit?

A limit implemented in a payer edit or a pharmacy system is enforced by someone who cannot see the diagnosis. The clinician who can see it is now arguing with a system rather than treating a patient. Whatever the merits of the number, the decision has relocated to the party with the least context.

Were opioid limits applied beyond the CDC guideline?

This is not speculative. The 2016 CDC guideline was written for primary care clinicians treating chronic pain outside cancer, palliative and end-of-life care. Between 2016 and 2018, 527 federal and state opioid-related policies were approved; 170 imposed prescribing limits, and 35 explicitly invoked the CDC guideline. It was applied to specialists, to established patients and to populations it excluded by name.

CDC said so itself in 2022, listing among the misapplications “extension to patient populations not covered,” “rigid application of opioid dosage thresholds,” “duration limits by insurers and pharmacies,” and “patient dismissal and abandonment.” It then removed the number from the recommendation entirely, stating that this was to discourage exactly that.

Did opioid prescribing limits reduce overdose deaths?

Prescribing fell. Opioid-involved overdose deaths rose from 42,435 in 2016 to 82,851 in 2022 — a 95% increase — before falling to 55,007 in 2024. Whatever was driving mortality across that period was substantially not the thing being regulated.

The general lesson

Any number issued as guidance will be implemented as a rule by every system downstream that needs something machine-readable. If you publish a threshold, assume it will be enforced as a ceiling by parties you did not address, against patients you excluded, and design accordingly — or do not publish a number.

More: dose thresholds and variability · the guidelines themselves.

Frequently asked questions

What are the CDC guidelines for opioid prescribing?

The 2016 CDC guideline was written for primary care clinicians treating chronic pain outside cancer, palliative and end-of-life care. It was then applied far more widely: between 2016 and 2018, 527 federal and state opioid-related policies were approved, 170 imposed prescribing limits, and 35 explicitly invoked the guideline. Specialists, established patients and excluded populations were all caught by it.

What are the new guidelines for prescribing opioids?

In 2022 CDC updated its guideline and named the ways the 2016 version had been misapplied, including extension to patient populations not covered, rigid application of opioid dosage thresholds, duration limits by insurers and pharmacies, and patient dismissal and abandonment. It then removed the number from the recommendation entirely, stating that this was to discourage exactly that kind of misuse.

What happens when a guideline number becomes a rule?

Any number issued as guidance gets implemented as a rule by every system downstream that needs something machine-readable, such as payer edits and pharmacy systems. Those systems enforce it without seeing the diagnosis, so the clinician ends up arguing with a system instead of treating a patient. A published threshold should be expected to act as a ceiling, even for patients it excluded.